Fluid Optimisation in Laparoscopic Colorectal Procedures
1 other identifier
interventional
60
1 country
1
Brief Summary
Goal-directed fluid therapy (GDFT) with hemodynamic monitoring may not be of benefit to all elective patients undergoing major abdominal surgery, particularly those managed in Enhanced Recovery After Surgery protocols (ERAS) setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 18, 2021
CompletedFirst Posted
Study publicly available on registry
January 22, 2021
CompletedJanuary 22, 2021
January 1, 2021
1 year
January 18, 2021
January 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of hospitalisation
1 month after admission
Secondary Outcomes (1)
Perioperative complications
8 days after surgery
Study Arms (2)
Control group
NO INTERVENTIONStandard perioperative anesthesia management
Study group
ACTIVE COMPARATORPerioperative extended haemodynamic monitoring of fluid loading, cardiac output and changes of peripheral vascular resistance by analysing the arterial curve was provided by non-invasive haemodynamic monitoring (LIDCO Rapid, Lidco Ltd., United Kingdom).In SG fluid optimisation was performed before pneumoperitoneum and after abdominal desuflation with actions to achieved CI, MAP and SI within 80% of baseline values.
Interventions
In case of stroke volume variation (SVV) \>10% and SI and CI \>10% below the starting value, fluid challenge was performed with approximately 2 ml/kg of colloid over maximum of 5 minutes. The response was monitored. If there was a fall in SVV and an increase in SI of \>10% and the SVV still \>10%, the second fluid challenge was performed. If there was still a reduction in SVV after the second fluid challenge, but an increase in nSI \<10% and decrease in systemic vascular resistance (SVR), no additional fluids were given. Vasoactive drugs were used instead.
Eligibility Criteria
You may qualify if:
- patients, undergoing elective laparoscopic colorectal surgery
You may not qualify if:
- Patients with cardiac arrhythmias
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alenka Spindler Vesel, asoc Prof
Department of anesthesiology and surgical intensive care
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- asist prof
Study Record Dates
First Submitted
January 18, 2021
First Posted
January 22, 2021
Study Start
June 1, 2017
Primary Completion
June 1, 2018
Study Completion
September 1, 2018
Last Updated
January 22, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share